非结核性菌根性肺病的宿主导疗法:临床前和临床数据审查
Ifeanyichukwu U Anidi1, Kenneth N Olivier2
1Pulmonary Division, National Heart, Lung and Blood Institute, National Institutes of Health, 33 North Drive, Room 1W10A, Bethesda, MD 20892, USA.
Clinics in chest medicine
|October 27, 2023
概括
非结核性菌根性肺病 (NTM-PD) 的标准治疗由于长期,复杂的抗生素治疗方案而具有挑战性. 主体导向疗法 (HDT) 提供了一个有希望的替代方案或补充,以改善患者的治疗结果.
科学领域:
- 肺部医学 肺部医学
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 非结核性菌根性肺病 (NTM-PD) 的标准治疗包括长期的多药抗菌疗法.
- 由于治疗的复杂性和副作用,患者和医生对当前NTM-PD治疗指南的坚持是不理想的.
- 对于有效管理NTM-PD的新型治疗策略有着至关重要的需求.
研究的目的:
- 审查对NTM-PD的宿主导疗法 (HDT) 的翻译研究和临床试验数据.
- 探索HDT在增强当前抗微生物治疗或提供替代方法方面的潜力.
- 突出治疗点,增强宿主对NTM-PD的保护性反应.
主要方法:
- 对现有文献的审查,重点是翻译研究和临床试验数据.
- 对调查宿主导治疗方式的研究进行分析.
- 专注于改善宿主机械保护和免疫反应的机制.
主要成果:
- 宿主导疗法 (HDT) 正在成为NTM-PD治疗的有希望的途径.
- 了解宿主免疫机制提供了新的治疗点.
- 高质量疗法有可能显著改善NTM-PD的治疗场景.
结论:
- 宿主导疗法是对抗NTM-PD的重要进展.
- 这些疗法旨在加强宿主对菌根菌感染的自然防御.
- 进一步的研究和临床试验至关重要,以充分实现HDTs在NTM-PD管理中的潜力.
更多相关视频
相关概念视频
Pulmonary Tuberculosis V
183
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
183
Pulmonary Tuberculosis IV
145
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
145
Pulmonary Tuberculosis II
243
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
243
Pulmonary Tuberculosis I
246
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
246
Pulmonary Tuberculosis III
339
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
339
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K


